Activity of osimetrinib/AZD9291 in pretreated patients (pts) with epidermal growth factor receptor mutant (EGFRmt) non-small cell lung cancer (NSCLC), according to EGFR mutations d... von Kontopodis, Emmanouil, Nuria, Jordana, Ntzifa, Aliki, Katsaounis, Panayiotis, Charalambous, Charalambos Haris, Boukovinas, Ioannis, Tsaroucha, Emily, Psyrri, Amanda, Koumarianou, Anna, Nikolaou, Michail, Kentepozidis, Nikolaos K., Rosell, Rafael, Georgoulias, Vassilis, Karachaliou, Niki, Kotsakis, Athanasios

Volltext

TTF1 status as a better predictor of benefit to erlotinib (E) in metastatic non-small cell lung cancer (NSCLC) than sex, histology, and smoking status von Charalambous, Charalambos Haris, Charalambous, Charis, Vomvas, Dimitrios, Katodritis, Nikos, Decatris, Marios P.

Volltext